Finlay, J., Mynarek, M., Dhall, G., Lafay-Cousin, L., Mazewski, C., Ashley, D., … Rutkowski, S. (2019). PDCT-03. CHEMOTHERAPY STRATEGIES FOR YOUNG CHILDREN NEWLY DIAGNOSED WITH MEDULLOBLASTOMA UP TO THE ERA OF MOLECULAR PROFILING – A COMPARATIVE OUTCOMES ANALYSIS. In Neuro-Oncology (Vol. 21, pp. vi183–vi184). Oxford University Press (OUP). https://doi.org/10.1093/neuonc/noz175.767

Finlay, Jonathan, Martin Mynarek, Girish Dhall, Lucie Lafay-Cousin, Claire Mazewski, David Ashley, Sarah Leary, et al. “PDCT-03. CHEMOTHERAPY STRATEGIES FOR YOUNG CHILDREN NEWLY DIAGNOSED WITH MEDULLOBLASTOMA UP TO THE ERA OF MOLECULAR PROFILING – A COMPARATIVE OUTCOMES ANALYSIS.” In Neuro-Oncology, 21:vi183–84. Oxford University Press (OUP), 2019. https://doi.org/10.1093/neuonc/noz175.767.

Finlay J, Mynarek M, Dhall G, Lafay-Cousin L, Mazewski C, Ashley D, et al. PDCT-03. CHEMOTHERAPY STRATEGIES FOR YOUNG CHILDREN NEWLY DIAGNOSED WITH MEDULLOBLASTOMA UP TO THE ERA OF MOLECULAR PROFILING – A COMPARATIVE OUTCOMES ANALYSIS. In: Neuro-Oncology. Oxford University Press (OUP); 2019. p. vi183–4.

Finlay, Jonathan, et al. “PDCT-03. CHEMOTHERAPY STRATEGIES FOR YOUNG CHILDREN NEWLY DIAGNOSED WITH MEDULLOBLASTOMA UP TO THE ERA OF MOLECULAR PROFILING – A COMPARATIVE OUTCOMES ANALYSIS.” Neuro-Oncology, vol. 21, no. Supplement_6, Oxford University Press (OUP), 2019, pp. vi183–84. Crossref, doi:10.1093/neuonc/noz175.767.

Finlay J, Mynarek M, Dhall G, Lafay-Cousin L, Mazewski C, Ashley D, Leary S, von Bueren A, Gerber N, Cohen B, Robinson G, Russell Geyer J, Tait D, Stanek J, Gajjar A, Rutkowski S. PDCT-03. CHEMOTHERAPY STRATEGIES FOR YOUNG CHILDREN NEWLY DIAGNOSED WITH MEDULLOBLASTOMA UP TO THE ERA OF MOLECULAR PROFILING – A COMPARATIVE OUTCOMES ANALYSIS. Neuro-Oncology. Oxford University Press (OUP); 2019. p. vi183–vi184.